article thumbnail

Pharma Sales Rep Pleads Guilty to Healthcare Fraud and Criminal HIPAA Violations

HIPAA Journal

A pharmaceutical sales rep has pleaded guilty to conspiring to commit healthcare fraud and wrongfully disclosing and obtaining patients’ protected health information in an elaborate healthcare fraud scheme involving criminal HIPAA violations. Ritson identified the patients through the medical practice of Dr. Frank Alario.

Fraud 59
article thumbnail

How Will New FDA Hearing Aid Regulations Impact Health Plans?

HIT Consultant

First, let’s examine the new regulatory framework the FDA established. The regulations may provide an opportunity for health insurers to attract new members – and retain existing ones – with hearing loss. – Fraud. Health plans should be on the alert for potential pitfalls arising from the new regulations.

FDA 98
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Digital Health in the Metaverse: Three Legal Considerations

Healthcare Law Blog

The FTC’s increasing interest in health information that sits outside of HHS/OCR’s reach is likely to only expand in light of health-related metaverse use cases. In response to the growth of the metaverse and digital health generally, the FDA has been working to expand its guidance in the area. Medical Device Regulations.

FDA 90
article thumbnail

Healthcare Supplier Compliance Checklist

MedTrainer

While adherence to these guidelines is voluntary, organizations implementing effective compliance programs are better equipped to identify and address potential compliance risks, mitigate fraud and abuse, and uphold the integrity of healthcare programs and services.

article thumbnail

Updated Compliance Tool for Developers of Mobile Health Apps

Hall Render

The Tool is a result of collaborative efforts between the FTC, HHS Office for Civil Rights (“OCR”), HHS Office of the National Coordinator for Health Information Technology (“ONC”) and the Food and Drug Administration (“FDA”). Regulatory Landscape.

article thumbnail

Is there an ROI on AI?

Health Blawg

Though, of course, at a certain point, an AI tool used in healthcare becomes subject to regulation by the FDA as a medical device ; folks need to be aware of those lines, and of the shifting regulatory landscape.) The hope, of course, is that the clinical uses can prove themselves out and become more widely adopted.

FDA 60
article thumbnail

Is there an ROI on AI?

Health Blawg

Of those health organizations that are already investing in and implementing AI: 43 percent are automating business processes, such as administrative operations or customer service. 36 percent are using AI to detect patterns in health care fraud, waste and abuse.

FDA 60